Opioid and stimulant co-prescribing does not equate to a co-epidemic
Saved in:
| Main Authors: | Kevin Young Xu, Richard A. Grucza, Vitor Soares Tardelli, Patrick D. Quinn, Jeffrey F. Scherrer |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-05-01
|
| Series: | The Lancet Regional Health. Americas |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2667193X25001036 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Opioid and stimulant co-prescribing: our efforts and remaining open questions—authors' reply
by: Wenyu Song, et al.
Published: (2025-05-01) -
Interpreting trends of opioid and stimulant co-prescribing in the United States: the need for attention to evidence-based prescribing practice in the context of co-occurring mental and or substance use disorders
by: Heather Palis, et al.
Published: (2025-05-01) -
The recent trend of twin epidemic in the United States: a 10-year longitudinal cohort study of co-prescriptions of opioids and stimulantsResearch in context
by: Seungyeon Lee, et al.
Published: (2025-04-01) -
Ten-year trends in opioid prescribing and vaso-occlusive crises in sickle cell disease: a population-based national cohort study (2011–2022)Research in context
by: Kevin Y. Xu, et al.
Published: (2025-10-01) -
Evaluation of physicians’ opioid prescribing practices, attitudes, and interactions with other healthcare professionals in optimizing opioid prescribing in Pakistan
by: Hafsa Arshad, et al.
Published: (2025-05-01)